NEW YORK (GenomeWeb) – Oxford Finance and Silicon Valley Bank said today that they have closed a $20 million credit facility with Castle Biosciences.

The credit facility comprises a $15 million senior secured term loan and a $5 million line of credit. Castle Bio, which is based in Friendswood, Texas, will use the proceeds to accelerate marketing and new product development related to its molecular prognostic tests for patients with underserved cancers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Dec
03
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.

Dec
04
Sponsored by
Sophia Genetics

This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.

Dec
12

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.